David Andrew Good

David Andrew Good is a Senior Lecturer in the Department of Anatomy & Pre-clinical Sciences at the School of Allied Health (part of the Faculty of Health Sciences). His research focuses on cancer immunotherapy, traditional medicine applications, and genomic studies in diabetes. He has contributed to breakthroughs in using toad toxins, clostridial spores, and microRNAs as diagnostic and therapeutic tools.

Research Interests: Dr. Good’s work spans oncology, immunology, and indigenous health. Key areas include:

• Development of natural product-based anticancer therapies
• Immunomodulation via cytokine signaling and biomarkers
• Genetic epidemiology of type 2 diabetes in Indigenous populations
• Innovative drug delivery systems using biomaterials

Research Trends: His articles highlight a focus on translational research bridging basic science and clinical application. Recent work emphasizes combinatorial immunotherapies for lung cancer, microbial-based cancer therapies, and biomarker discovery using microRNAs.

Collaborations: Dr. Good has collaborated extensively on interdisciplinary projects involving molecular biologists, oncologists, and indigenous health researchers. His work often combines traditional medicine insights with modern genomic techniques.

Labs/Teams: While specific lab affiliations aren’t detailed, his collaborative projects suggest involvement with cancer biology, immunology, and biomaterials research groups.